Pig kidney functioned for 271 days before human donor transplant

Kidney failure can require recurring dialysis while patients wait for an organ, and the supply gap remains large. The BBC reports that about 100,000 people in the US are waiting for a kidney, compared with roughly 25,000 kidney transplants each year; more than 7,000 people are on the UK kidney transplant list. A temporary functioning organ could, if future studies support its safety and durability, give some patients another option during that wait. The immediate practical consequence of this single case was time away from dialysis, not proof of a broadly available treatment.

Xenotransplantation uses organs from another species in human recipients. Pigs are being investigated because their organs are broadly comparable in size to human organs and they can be bred for this purpose. The central biological obstacle is that the human immune system can rapidly recognize pig tissue as foreign and attack it. In this case, genetic changes were designed to remove pig-cell features that provoke immune recognition, add human genetic material intended to improve compatibility, and disable certain pig viruses. The 271-day duration adds clinical observation beyond very short-term function, including an episode of suspected rejection that responded to medication changes. It also occurred in a patient who ultimately received a human donor kidney, illustrating the team’s proposed use case: maintaining a patient until conventional transplantation becomes possible. The available report does not provide evidence that this approach can yet address organ scarcity at population scale.

The result is one patient’s experience, so it cannot show how often similar outcomes would occur or which patients might benefit. The pig kidney did not provide a permanent solution: after around six months, vascular damage and inflammation developed, and the organ was removed. Doctors said there were no signs that antibodies were attacking the kidney, leaving the cause of its eventual failure unresolved. The case also involved extensive genetic modification of the donor pig and specialist clinical care, factors that may limit how readily the procedure can be replicated. Longer follow-up and additional patients are needed to assess durability, immune risks and infection safeguards.